Table 2 Univariate analysis of clinical factors associated with survival time since hospice ward admission

Sex

-0.115

0.148

Age

0.001

0.987

Age > = 65 years old

0.069

0.386

Charlson comorbidity index

0.023

0.774

Palliative prognostic index

-0.305**

 < 0.001

Palliative prognostic score

-0.352**

 < 0.001

Hospice ward hospitalization days

0.710**

 < 0.001

Cancer Sites

 Hepatobiliary cancer

-0.174*

0.028

 Urogenital system cancer

-0.059

0.461

 Breast cancer

-0.069

0.384

 Colorectal cancer

-0.024

0.762

 Lung cancer

-0.054

0.500

 Esophageal and Gastric cancer

0.110

0.164

 Head and Neck cancer

0.273*

 < 0.001

 Others

0.035

0.663

Cancer Metastases sites

 Brain metastases

0.058

0.465

 Lymph node metastases

-0.027

0.738

 Lung metastases

-0.020

0.799

 Liver metastases

-0.228**

0.004

 Bone metastases

-0.018

0.824

Activity daily living < 20 when admission

0.068

0.392

Laboratory data

 Neutrophil percentage

-0.109

0.169

 Lymphocyte percentage

0.078

0.329

 Neutrophil to lymphocyte ratio

-0.170*

0.032

 Nasogastric tube use

0.069

0.385

 Feeding gastrostomy or jejunostomy

0.400**

 < 0.001

 Tracheostomy

0.342**

 < 0.001

 Foley catheter use

-0.057

0.476

Treatments when starting hospice ward admission

 Parenteral nutrition use

0.000

1

 Antibiotic use

-0.169*

0.033

 Oxygen use

-0.070

0.377

Treatments during hospice ward hospitalization

 Subcutaneous morphine use

-0.119

0.135

 Total sedation

0.221**

0.005

 Blood transfusion

0.327**

 < 0.001

 Parenteral nutrition

0.048

0.549